Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Optical Monitoring of Cerebral Perfusion as Perturbed by an Ischemic Stroke in an Adult Human

Not Accessible

Your library or personal account may give you access

Abstract

For patients with ischemic stroke there is benefit to early treatment (within 3 hours) with recombinant tissue plasminogen activator, rt-PA, an FDA approved thrombolytic drug.

© 1999 Optical Society of America

PDF Article
More Like This
Clinical Trial on Bedside Monitoring of Cerebral Perfusion in Acute Stroke by Time-Domain Near-Infrared Reflectometry

O. Steinkellner, H. Wabnitz, R. Macdonald, C. Gruber, J. Steinbrink, P. Brunecker, H. Müller, G. J. Jungehülsing, J. B. Fiebach, and H. Obrig
BTuB5 Biomedical Optics (BIOMED) 2010

Bedside monitoring of cerebral blood flow in the hyper-acute phase of ischemic stroke

Peyman Zirak, Raquel Delgado-Mederos, Igor Blanco, Lavinia Dinia, David Carrera, Joan Martí-Fàbregas, and Turgut Durduran
BM3A.11 Biomedical Optics (BIOMED) 2014

Optical Monitoring of Cerebral Blood Flow in Patients with Acute Ischemic Stroke During Intravenous Administration of Normal Saline

Ashwin B Parthasarathy, Steve S Schenkel, David R Busch, Kenneth Abramson, Julien Menko, Wesley B Baker, Malavika Chandra, Michael Mullen, John A Detre, and Arjun G Yodh
BW2B.5 Biomedical Optics (BIOMED) 2014

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.